Skip to main content
Equibles

Ameritas Investment Partners, Inc.

Position in NERV — Minerva Neurosciences, Inc.

CIK 1055980 LINCOLN, NE
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,149
+$10,708 QoQ
Shares Held
3,090
+1019.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 58 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. NERV ranks #218 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 12,422 $6,170,379
2 EXEL
Exelixis, Inc.
 75,969 $4,133,473
3 HALO
Halozyme Therapeutics, Inc.
 40,729 $3,187,858
4 CYTK
Cytokinetics Inc
 36,992 $3,151,348
5 ROIV
Roivant Sciences Ltd.
 83,064 $2,939,634
6 REGN
Regeneron Pharmaceuticals, Inc.
 4,593 $2,863,919
7 JAZZ
Jazz Pharmaceuticals plc
 11,547 $2,782,480
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 25,923 $2,112,983

All Filings in NERV

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,149 3,090
2021-03-31 $6,441 2,206
2020-12-31 $5,162 2,206
2020-09-30 $7,015 2,206
2020-06-30 $7,963 2,206
2020-03-31 $13,280 2,206